US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.
The market research available can provide investors and analysts credible information on the direction of pharmaceuticals, anesthesia, drug delivery, pricing, regulations and policy being developed to ensure that knowledgeable and informed decisions are made regarding industry direction.
  • Biopharmaceuticals (221)
  • Diseases & Conditions (4427)
  • Drug Delivery (186)
  • Therapeutic Area (7015)
  • Vaccines (643)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Out-of-Pocket Healthcare Expenditures in the United States
5/15/2015 | published by: Kalorama Information
... is the result of a variety of factors including an aging U.S. population, rising utilization of medical products and services, and ongoing cutbacks to both public (federal and state) and private health coverage. Over the ...  |  read more...
USD 1,500
Cardiac Rhythm Management Device Markets
5/1/2015 | published by: Kalorama Information
... particularly arrhythmias and congestive heart failure. This report,  C ardiac Rhythm Device Markets,  includes cardiac rhythm management devices with both external and internal applications.  Major segments include defibrillators: electrical devices that deliver therapeutic levels of ...  |  read more...
USD 3,995
Genital Herpes-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Genital Herpes Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Genital Herpes- Pipeline ...  |  read more...
USD 1,250
Gingivitis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Gingivitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Gingivitis- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Gliosarcoma-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Gliosarcoma Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Gliosarcoma- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Leukotriene D4 Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Leukotriene D4 Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Gouty Arthritis (Gout)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Gouty Arthritis (Gout) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Graft Versus Host Disease (GVHD)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Graft Versus Host Disease (GVHD) Report helps to identify emerging players with potentially strong product information ...  |  read more...
USD 1,250
Lipoprotein-Associated Phospholipase A2 (Lp-PLA2 or Platelet Activating Factor Acetyl-Hydrolase) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... pipeline assets across the Lipoprotein-Associated Phospholipase A2 (Lp-PLA2 or Platelet Activating Factor Acetyl-Hydrolase) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The ...  |  read more...
USD 1,250
Lipoxygenase Inhibitors (LOX Inhibitor) -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Lipoxygenase Inhibitors (LOX Inhibitor) Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors . The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors ...  |  read more...
USD 1,250
Gram-Negative Bacterial Infections-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Gram-Negative Bacterial Infections Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Grass Pollen Allergy-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Grass Pollen Allergy Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Growth Hormone Deficiency-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Growth Hormone Deficiency Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Guillain-Barre Syndrome-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Guillain-Barre Syndrome Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Guillain-Barre Syndrome- Pipeline ...  |  read more...
USD 1,250
Gynecological Cancer-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Gynecological Cancer Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Gynecological Cancer- Pipeline ...  |  read more...
USD 1,250
H3N2 Infection-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The H3N2 Infection Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, H3N2 Infection- Pipeline ...  |  read more...
USD 1,250
Head And Neck Cancer Squamous Cell Carcinoma-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Cancer Squamous Cell Carcinoma. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Head And Neck Cancer Squamous Cell Carcinoma Report helps to ...  |  read more...
USD 1,250
Helicobacter Pylori Infections-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Helicobacter Pylori Infections Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Hemophilia A-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hemophilia A Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Hemophilia A- Pipeline ...  |  read more...
USD 1,250
Hemophilia B-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hemophilia B Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Hemophilia B- Pipeline ...  |  read more...
USD 1,250
Hemorrhagic Fever-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hemorrhagic Fever Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Hemorrhagic Fever- Pipeline ...  |  read more...
USD 1,250
Hemorrhagic Shock-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hemorrhagic Shock Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Hemorrhagic Shock- Pipeline ...  |  read more...
USD 1,250
Hepatic - Colorectal Metastasis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hepatic - Colorectal Metastasis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies ...  |  read more...
USD 1,250
LTB4 Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The LTB4 Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, LTB4 Antagonists- ...  |  read more...
USD 1,250
< prev 1    3  4  5  6  7  8  9  10